Local manufacturing of protein-based vaccines and therapies in Africa is limited and contributes to a trade deficit, security of supply concerns and poor access to biopharmaceuticals by the poor. Plant molecular farming is a potential technology solution that has received growing adoption by African scientists attracted by the potential for the competitive cost of goods, safety and efficacy. Plant-made pharmaceutical technologies for veterinary and human vaccination and treatment of non-communicable and infectious diseases are available at different stages of development in Africa. There is also growth in the translation of these technologies to commercial operations. Africa is poised to benefit from the real-world impact of molecular farming in the next few years.

中文翻译：

---

在非洲进行分子疗法和疫苗的农业。

非洲当地生产基于蛋白质的疫苗和疗法的局限性，加剧了贸易逆差，供应安全问题以及穷人获取生物药品的途径。植物分子农业是一种潜在的技术解决方案，受到商品价格，安全性和功效的竞争潜力的吸引，被非洲科学家越来越多地采用。在非洲的不同发展阶段，可以使用用于兽医和人类疫苗接种以及治疗非传染性和传染性疾病的植物制药技术。这些技术向商业运作的转化也有所增长。非洲有望在未来几年中受益于分子农业的现实世界影响。